Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Cannabidiol for Chronic Musculoskeletal Joint Pain
NCT05002114Phase 1Withdrawn
- Sponsor
- LSU Health Shreveport
- Start
- Jan 2023
- Primary completion
- Jan 2023
01
Overview
Phase 1, randomised, double-blind trial of Zygel in Musculoskeletal pain (2 arms), sponsored by LSU Health Shreveport. Primary endpoints: Patient Global Impression of Severity at 4 weeks, Patient Global Impression of Change at 4 weeks and 1 more. Planned start Jan 2023; status: withdrawn.
02
Drugs
Zygel
03
Conditions
Musculoskeletal pain
Beyond the preview
Go deeper on NCT05002114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05002114.